Paper · 39741663
References49
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
1 to 20 of 49
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 35400496 | Semaglutide reduces vascular inflammation investigated by PET in a rabbit model of advanced atherosclerosis. | Atherosclerosis | 2022 | https://conductscience.org/library/papers/35400496 | PubMed |
| 2 | 23868944 | Cardioprotective effects of exenatide in patients with ST-segment-elevation myocardial infarction undergoing primary percutaneous coronary intervention: results of exenatide myocardial protection in revascularization study. | Arterioscler Thromb Vasc Biol | 2013 | https://conductscience.org/library/papers/23868944 | PubMed |
| 3 | 34356845 | Inflammatory Mechanisms Contributing to Endothelial Dysfunction. | Biomedicines | 2021 | https://conductscience.org/library/papers/34356845 | PubMed |
| 4 | 19195607 | Exenatide reduces infarct size and improves cardiac function in a porcine model of ischemia and reperfusion injury. | J Am Coll Cardiol | 2009 | https://conductscience.org/library/papers/19195607 | PubMed |
| 5 | 36799940 | Human epicardial adipose tissue expresses glucose-dependent insulinotropic polypeptide, glucagon, and glucagon-like peptide-1 receptors as potential targets of pleiotropic therapies. | Eur J Prev Cardiol | 2023 | https://conductscience.org/library/papers/36799940 | PubMed |
| 6 | 37522848 | Protective effect of GLP-1 analog liraglutide on podocytes in mice with diabetic nephropathy. | Endocr Connect | 2023 | https://conductscience.org/library/papers/37522848 | PubMed |
| 7 | 19955250 | Chronic coronary artery disease: diagnosis and management. | Mayo Clin Proc | 2009 | https://conductscience.org/library/papers/19955250 | PubMed |
| 8 | 31446075 | New Insights into Beta-Cell GLP-1 Receptor and cAMP Signaling. | J Mol Biol | 2020 | https://conductscience.org/library/papers/31446075 | PubMed |
| 9 | 24267262 | Glucagon-like peptide-1 (GLP-1) and its split products GLP-1(9-37) and GLP-1(28-37) stabilize atherosclerotic lesions in apoe⁻/⁻ mice. | Atherosclerosis | 2013 | https://conductscience.org/library/papers/24267262 | PubMed |
| 10 | 26630143 | Lixisenatide in Patients with Type 2 Diabetes and Acute Coronary Syndrome. | N Engl J Med | 2015 | https://conductscience.org/library/papers/26630143 | PubMed |
| 11 | 31447282 | Inflammation in atherosclerosis: A key role for cytokines. | Cytokine | 2019 | https://conductscience.org/library/papers/31447282 | PubMed |
| 12 | 27110066 | Anti-Inflammatory Effects of GLP-1-Based Therapies beyond Glucose Control. | Mediators Inflamm | 2016 | https://conductscience.org/library/papers/27110066 | PubMed |
| 13 | 15616022 | Glucagon-like peptide 1 can directly protect the heart against ischemia/reperfusion injury. | Diabetes | 2005 | https://conductscience.org/library/papers/15616022 | PubMed |
| 14 | 20068138 | Inhibition of monocyte adhesion to endothelial cells and attenuation of atherosclerotic lesion by a glucagon-like peptide-1 receptor agonist, exendin-4. | Diabetes | 2010 | https://conductscience.org/library/papers/20068138 | PubMed |
| 15 | 36317383 | Inflammation in coronary artery disease-clinical implications of novel HDL-cholesterol-related inflammatory parameters as predictors. | Coron Artery Dis | 2023 | https://conductscience.org/library/papers/36317383 | PubMed |
| 16 | 31002893 | GLP-1: Molecular mechanisms and outcomes of a complex signaling system. | Neurochem Int | 2019 | https://conductscience.org/library/papers/31002893 | PubMed |
| 17 | 30291013 | Albiglutide and cardiovascular outcomes in patients with type 2 diabetes and cardiovascular disease (Harmony Outcomes): a double-blind, randomised placebo-controlled trial. | Lancet | 2018 | https://conductscience.org/library/papers/30291013 | PubMed |
| 18 | 31270216 | Liraglutide Attenuates Preestablished Atherosclerosis in Apolipoprotein E-Deficient Mice via Regulation of Immune Cell Phenotypes and Proinflammatory Mediators. | J Pharmacol Exp Ther | 2019 | https://conductscience.org/library/papers/31270216 | PubMed |
| 19 | 26447224 | The physiological role of glucagon-like peptide-1 in the regulation of renal function. | Am J Physiol Renal Physiol | 2016 | https://conductscience.org/library/papers/26447224 | PubMed |
| 20 | 31185157 | Oral Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes. | N Engl J Med | 2019 | https://conductscience.org/library/papers/31185157 | PubMed |
papers-2026-11-12-0.1.0
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/papers/v1/39741663/references